Kanasaki, K., Nagai, T., Nitta, K., Kitada, M., & Koya, D. (2014). N-acetyl-seryl-aspartyl-lysyl-proline: A valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes. Frontiers Media S.A.
Citação norma ChicagoKanasaki, Keizo, Takako Nagai, Kyoko Nitta, Munehiro Kitada, and Daisuke Koya. N-acetyl-seryl-aspartyl-lysyl-proline: A Valuable Endogenous Anti-fibrotic Peptide for Combating Kidney Fibrosis in Diabetes. Frontiers Media S.A, 2014.
MLA CitationKanasaki, Keizo, et al. N-acetyl-seryl-aspartyl-lysyl-proline: A Valuable Endogenous Anti-fibrotic Peptide for Combating Kidney Fibrosis in Diabetes. Frontiers Media S.A, 2014.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.